Taken together, these findings suggest that lower DNMT enzyme activity possibly caused by the heterogeneous DNMT1 variant in the KURC3 PDX tumor was associated with the acquired phenotype of temsirolimus resistance. The gene discussed is DNMT1; the disease is neoplasm.